Coronavirus vaccines may be less effective for Black and Asian recipients, MIT study suggests


Promising results from Moderna, Pfizer, and AstraZeneca's coronavirus vaccines have raised hopes that an end to the pandemic may be in sight. But distribution issues aside, a study from the Massachusetts Institute of Technology out last week is raising further concerns about those vaccines' effectiveness.
After initial human trials, Moderna reported its vaccine to be 94 percent effective in preventing coronavirus transmission, while Pfizer's was 95 percent effective and AstraZeneca's 70 percent. But these vaccines, along with many others still in development, share a potential weakness, MIT researchers report. Researchers used artificial intelligence and machine learning to examine a vaccine similar to these big developers', and found that while less than 0.5 percent of white trial participants didn't respond strongly to the vaccine, nearly 10 percent of Asian participants didn't. This could mean "people of Black or Asian ancestry could have a slightly increased risk of vaccine ineffectiveness," the study's senior author David Gifford said in an article accompanying the study.
A lack of diversity in the vaccine trial pools may have led developers to calibrate the vaccine to a specific version of human genes — white people's genes in particular. But MIT researchers did offer a potential solution: "adding a small number of additional COVID-19 peptides" — strings of amino acids that make up proteins, which in turn make up a coronavirus — "to a given dose of the vaccine," MIT's Computer Science and Artificial Intelligence lab writes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The study's results highlight longstanding trends in health care" and clinical trials, Health IT Analytics notes. Minority groups are often underrepresented in trials, making it less certain how effective vaccines and drugs will be for them and potentially leading to the formulation of vaccines that are tailored for white people. That's especially troubling amid the coronavirus pandemic, as Black and brown people have disproportionately been hospitalized with and died of the virus.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
Trump uses tariffs to upend Brazil's domestic politics
IN THE SPOTLIGHT By slapping a 50% tariff on Brazil for its criminal investigation into Bolsonaro, the Trump administration is brazenly putting its fingers on the scales of a key foreign election
-
3 questions to ask when deciding whether to repair or replace your broken appliance
the explainer There may be merit to fixing what you already have, but sometimes buying new is even more cost-effective
-
'Trump's authoritarian manipulation of language'
Instant Opinion Vienna has become a 'convenient target for populists' | Opinion, comment and editorials of the day
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths